Delivery after bone marrow transplantation with total lymphoid irradiation for severe aplastic anemia
スポンサーリンク
概要
著者
-
Tsubaki K
Kinki Univ. School Of Medicine Osaka Jpn
-
ASHIDA T.
Third Department of Internal Medicine, Kinki University School of Medicine
-
TSUBAKI K.
Third Department of Internal Medicine, Kinki University School of Medicine
-
Urase F.
Third Department Of Internal Medicine Kinki University School Of Medicine
-
HAZU S.
Third Department of Internal Medicine, Kinki University School of Medicine
-
ISHIKAWA H.
Third Department of Internal Medicine, Kinki University School of Medicine
-
HORIUCHI A.
Third Department of Internal Medicine, Kinki University School of Medicine
-
Ashida T
Kinki Univ. School Of Medicine Osaka Jpn
-
Ashida T.
Third Department Of Internal Medicine Kinki University School Of Medicine
-
Hazu S.
Third Department Of Internal Medicine Kinki University School Of Medicine
-
Tsubaki K.
Third Department Of Internal Medicine Kinki University School Of Medicine
関連論文
- In vivo Retrovirus-mediated Herpes Simplex Virus Thymidine Kinase Gene Therapy Approach for Adult T Cell Leukemia in a Rat Model
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- The clinical characteristics of CD7^+ CD56^+ acute myeloid leukemias other than M0
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
- No beneficial effect from addition of etoposide to daunorubicin,cytarabine,and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia:the JALSG-AML92 study
- Case-control study of leukemia and diagnostic radiation exposure
- Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
- Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991
- Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult oatients with acute lymphoblastic leukemia: The ALL-87 Study of the Japan Adult Leukemia Study Group (JALSG)
- Pregnancy among long-term survivors of acute leukemia. A second nationwide survey
- Multicenter Prospective Study of Interferon-α and Conventional Chemotherapy Versus Bone Marrow Transplantation for Newly Diagnosed Patients With Chronic Myelogenous Leukemia
- Central nervous system involvement in intravascular large B-cell lymphoma : A retrospective analysis of 109 patients
- Systemic Mastocytosis with Extensive Polypoid Lesions in the Intestines; Successful Treatment with Interferon-α
- Adhesion-dependent growth of primary adult T cell leukemia cells with down-regulation of HTLV-I p40Tax protein : a novel in vitro model of the growth of acute ATL cells
- Deoxycoformycin-Containing Combination Chemotherapy for Adult T-Cell Leukemia-Lymphoma : Japan Clinical Oncology Group Study (JCOG9109)
- A Novel Plasmacytoid Dendritic Cell Line, CAL-1, Established from a Patient with Blastic Natural Killer Cell Lymphoma
- Clinical and Oncologic Implications in Epigenetic Down-Regulation of CD26/Dipeptidyl Peptidase IV in Adult T-Cell Leukemia Cells
- High-resolution melting analysis for a reliable and two-step scanning of mutations in the tyrosine kinase domain of the chimerical bcr-abl gene.
- Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia : a single-center analysis of 47 patients
- Durable Remission by Sobuzoxane in an HIV-Seronegative Patient with Human Herpesvirus 8-Negative Primary Effusion Lymphoma
- Clinical differences between hypoplastic and normocellular or hyperplastic myelodysplastic syndrome
- Comparative effects of three nitrosourea derivatives on cell cycle kinetics
- Flow Microfluorometric Analysis of Cell Kinetics with Antileukemic Drugs
- Differences in Mitogen Response and Suppressor Function of Two Human T Cell Subsets
- Successful Graft-Versus-Leukemia Effect of Second Bone Marrow Transplantation on Relapsed Leukemia Cutis That Was Refractory to Intensive Chemotherapy and Donor Lymphocyte Transfusions in a Patient With Acute Monocytic Leukemia
- Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma
- Change of serum erythropoietin levels after allogeneic bone marrow transplantation
- Changes in M-CSF activity and CFU-GM- Inhibitory activity in the urine of patient with cyclic chronic myelogenous leukemia
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Age-related EBV-associated B-cell lymphoproliferative disorders : Diagnostic approach to a newly recognized clinicopathological entity
- Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphoma
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
- Delivery after bone marrow transplantation with total lymphoid irradiation for severe aplastic anemia
- EFFECT OF IMMUNOADSORPTION THERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS